ALETA-003

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameALETA-003
Drug Alias NameALETA-003ALETA003ALETA 003
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCD276 antigen modulatorsReceptor protein-tyrosine kinase erbB-2 modulatorsImmunostimulants +[4] 
TargetsCD276 antigenReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAleta BioTherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAleta BioTherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A